We use cookies for a better user experience. Read our Privacy Policy

I Agree

Dyschromia Therapeutics Market

Dyschromia Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Dyschromia Therapeutics: Introduction

Dyschromia refers to a condition marked by any irregular discoloration on the skin, hair or nails, which can present as single or multiple light or dark patches on the skin. A large part of the dyschromia treatment market is saturated and highly generalized. There is an unmet need for more efficacious and safer treatment options, as the available treatments are associated with poor efficacy, low patient compliance, and problematic safety profiles. For instance, Sirona Biochem Corp.’s TFC-1067 demonstrates superior efficacy to hydroquinone, the gold standard, for the treatment of dyschromia. At present, hydroquinone is the gold standard treatment for skin lightening, despite known toxicity, which is an ongoing concern for the FDA and the dermatology community.

Key Drivers and Restraints of Global Dyschromia Therapeutics Market

  • Increase in awareness about skin issues is boosting the demand for dyschromia treatment. Patients are now more pro-active about their health and are willing to seek physician's advice at an early stage. Increase in awareness about the importance of personal appearance and personality development is another major factor driving the global dyschromia treatment market. In a study conducted by Center for Dermatology Research, around 80% of the participants in the U.S. were diagnosed with one or more pigmentation disorders. About 47.3% of the patients admitted to feeling self-conscious about their skin to some degree, 21.8% felt others focused on their skin, 32.7% felt unattractive because of their skin, 32.7% tried to hide their pigmentation, and 23.6% felt their skin affected their activities.
  • Adoption of laser-based devices has been rising due to the wide utility of laser devices. Applications include skin photo damage, hyperpigmentation and hypopigmentation, removal of unwanted hair, acnes, wrinkles, tattoo removal, facial vein removal, and body contouring. Cost-effectiveness and versatility of laser devices are also major factors driving the adoption and usage of laser procedures in the dyschromia treatment market.
  • Dyschromia adversely impacts a person's quality of life. Increase in disposable income of the people has led to an improvement in the standard of living in developed and emerging economies of the world. Additionally, rise in pigmentation disorders across age-groups and increase in expenditure on personal care are driving the demand for dyschromia treatment.

North America to Lead Global Dyschromia Therapeutics Market

  • In terms of region, the global dyschromia therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are likely to account for major share of the global dyschromia therapeutics market during the forecast period, owing to developed health care infrastructure, large patient population, and increase in technological developments in these regions.

Key Players Operating in Global Dyschromia Therapeutics Market

  • The global dyschromia therapeutics market is fragmented, with the presence of less number of small-scale companies in drug development. The global dyschromia treatment market is built on the principle of new product innovation. Major market players invest significantly in research and development to improve the effectiveness of products, such as skin whitening cosmetics, chemical peels in combination with topicals, and multi-utility pigmentation skin care products.
  • The treatment landscape for dyschromia has been traditionally dominated by generalized topical therapies such as hydroquinone
  • Research in dyschromia has led to the development of topical drugs and phototherapy, with the ability to target specific mediators involved in dyschromia.  Unmet needs in dyschromia therapeutics are creating significant opportunities for investors. Investment in R&D of cost-effective solutions is a focus area of major companies. This is expected to boost the global dyschromia therapeutics market in the next few years.

Leading companies operating in the global dyschromia therapeutics market are:

  • Bayer AG
  • ALLERGAN (AbbVie Inc.)
  • Galderma S.A. (Nestle Skin Health S.A)
  • SkinCeuticals
  • Pierre Fabre
  • EpiPharm AG
  • RXi Pharmaceuticals Corporation
  • Obagi Cosmeceuticals LLC (Obagi medical)
  • Vivier Pharma
  • Sirona Biochem's
  • Menarini Group

Global Dyschromia Therapeutics Market: Research Scope

Global Dyschromia Therapeutics Market, by Therapy

  • Topical Creams
    • Topical Steroids
    • Depigmenting Agents
    • Others
  • Laser Therapy
  • Phototherapy
  • Vitamin C Iontophoresis
  • Microneedling
  • Others

Global Dyschromia Therapeutics Market, by End-user

  • Hospitals
  • Esthetic Clinics & Dermatology Centers
  • Others

Global Dyschromia Therapeutics Market, by Route of Administration

  • Topical
  • Patch
  • Others

Global Dyschromia Therapeutics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

769

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved